NEW YORK (GenomeWeb News) – Affymetrix said today that Fisher Scientific will distribute its GeneAtlas System and related consumables in the US and Canada.
The company said that the distribution partnership with the Thermo Fisher Scientific business unit will expand its commercial sales in research markets.
"Now we have a partner with the industry's strongest customer channel to take this technology to the broadest life scientist community, which is key to the GeneAtlas System's success," Andy Last, chief commercial officer at Affymetrix, said in a statement.
Affy describes the GeneAtlas as a benchtop system that provides an "end-to-end solution for processing the industry's most widely cited gene expression arrays and analyzing biological pathways."
GeneAtlas is designed with four arrays per strip and offers simplified hybridization, robust protection for samples, limited hands-on time, and simple array processing, according to the company.
The system includes stations for hybridization, fluidics, and imaging, as well as a computer station, a barcode reader, and instrument control software.
Fisher Scientific President Dan Pantano said that the distribution agreement for the GeneAtlas "broadens our extensive genomic research portfolio and allows us to offer a full suite of solutions from discovery research through to validation."